Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M F Hou

Showing results (41-50 of 50) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 50 results.
Gaoxiong Yi Xue Ke Xue Za Zhi = the Kaohsiung Journal of Medical Sciences|December 1, 1995
Comparison of serum CA15-3 and CEA in breast cancerM F Hou, T J Huang, J S Hsieh, et al.
The Kaohsiung Journal of Medical Sciences|November 24, 1999
Evaluation of serum CA27.29, CA15-3 and CEA in patients with breast cancerM F Hou, Y L Chen, T F Tseng, et al.
The Kaohsiung Journal of Medical Sciences|October 13, 1999
Biochemical markers for assessment of bone metastases in patients with breast cancerM F Hou, L Y Tsai, S M Tsai, et al.
Neoplasma|February 5, 2013
Distant metastasis in triple-negative breast cancerL M Tseng, N C Hsu, S C Chen, et al.
The Kaohsiung Journal of Medical Sciences|February 28, 2001
Familial breast cancer in southern TaiwanM F Hou, K B Tsai, H M Fan, et al.
Human Genetics|May 14, 1999
Molecular characterization of germline mutations in the BRCA1 and BRCA2 genes from breast cancer families in TaiwanS S Li, H M Tseng, T P Yang, et al.
Oncogene|March 11, 2014
MicroRNA-149 targets GIT1 to suppress integrin signaling and breast cancer metastasisS-H Chan, W-C Huang, J-W Chang, et al.
Oncogene|October 10, 2017
Resistin facilitates breast cancer progression via TLR4-mediated induction of mesenchymal phenotypes and stemness propertiesC-H Wang, P-J Wang, Y-C Hsieh, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 21, 2026
Datopotamab deruxtecan (Dato-DXd) in combination with durvalumab as first-line treatment for unresectable locally advanced or metastatic triple-negative breast cancer: results from arms 7 and 8 of the phase Ib/II BEGONIA studyP Schmid, H-C Wang, F Lynce, et al.
British Journal of Cancer|February 20, 2014
FGF receptor genes and breast cancer susceptibility: results from the Breast Cancer Association ConsortiumD Agarwal, S Pineda, K Michailidou, et al.
Pageof 5

Showing results (41-50 of 50) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
Gaoxiong Yi Xue Ke Xue Za Zhi = the Kaohsiung Journal of Medical Sciences|December 1, 1995
Comparison of serum CA15-3 and CEA in breast cancerM F Hou, T J Huang, J S Hsieh, et al.
The Kaohsiung Journal of Medical Sciences|November 24, 1999
Evaluation of serum CA27.29, CA15-3 and CEA in patients with breast cancerM F Hou, Y L Chen, T F Tseng, et al.
The Kaohsiung Journal of Medical Sciences|October 13, 1999
Biochemical markers for assessment of bone metastases in patients with breast cancerM F Hou, L Y Tsai, S M Tsai, et al.
Neoplasma|February 5, 2013
Distant metastasis in triple-negative breast cancerL M Tseng, N C Hsu, S C Chen, et al.
The Kaohsiung Journal of Medical Sciences|February 28, 2001
Familial breast cancer in southern TaiwanM F Hou, K B Tsai, H M Fan, et al.
Human Genetics|May 14, 1999
Molecular characterization of germline mutations in the BRCA1 and BRCA2 genes from breast cancer families in TaiwanS S Li, H M Tseng, T P Yang, et al.
Oncogene|March 11, 2014
MicroRNA-149 targets GIT1 to suppress integrin signaling and breast cancer metastasisS-H Chan, W-C Huang, J-W Chang, et al.
Oncogene|October 10, 2017
Resistin facilitates breast cancer progression via TLR4-mediated induction of mesenchymal phenotypes and stemness propertiesC-H Wang, P-J Wang, Y-C Hsieh, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 21, 2026
Datopotamab deruxtecan (Dato-DXd) in combination with durvalumab as first-line treatment for unresectable locally advanced or metastatic triple-negative breast cancer: results from arms 7 and 8 of the phase Ib/II BEGONIA studyP Schmid, H-C Wang, F Lynce, et al.
British Journal of Cancer|February 20, 2014
FGF receptor genes and breast cancer susceptibility: results from the Breast Cancer Association ConsortiumD Agarwal, S Pineda, K Michailidou, et al.
Pageof 5